Neurovigil

Mountain View, United States Founded: 2007 • Age: 19 yrs
Solution provider for analysis of brain data in medical applications
Request Access

About Neurovigil

Neurovigil is a company based in Mountain View (United States) founded in 2007.. Neurovigil has raised $250 thousand across 3 funding rounds from investors including DFJ, Zone Ventures and Draper Frontier. Neurovigil offers products and services including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS). Neurovigil operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Ceribell, among others.

  • Headquarter Mountain View, United States
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Neurovigil, Inc
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $250 K (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
    DFJ

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Neurovigil

Neurovigil offers a comprehensive portfolio of products and services, including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Portable EEG for real-time brain activity analysis and disease detection

Software for automated EEG data processing and sleep pattern recognition

Technology for interpreting brain signals in research applications

People of Neurovigil
Headcount 1-10
Employee Profiles 2
Employee Profiles
People
Rebecca Brown
Proud And Fearless Member Of The Manhattan Project For The Brain™

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Neurovigil

Neurovigil has successfully raised a total of $250K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (30 May 2008)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2015 Amount Series B - Neurovigil Valuation

investors

May, 2011 Amount Series A - Neurovigil Valuation

investors

May, 2008 Amount Seed - Neurovigil Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Neurovigil

Neurovigil has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include DFJ, Zone Ventures and Draper Frontier. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
US focused VC firm
Founded Year Domain Location
-
Founded Year Domain Location
Seed & early-stage micro VC firm investing in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Neurovigil

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Neurovigil

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Neurovigil Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Neurovigil

Neurovigil operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Ceribell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Portfolio of products and services for life science research and clinical diagnostic markets
domain founded_year HQ Location
AI-based medical diagnostics are developed for healthcare applications.
domain founded_year HQ Location
Merck is engaged in science and technology solutions globally.
domain founded_year HQ Location
Assay kits for ultra-sensitive biomarker detection are developed.
domain founded_year HQ Location
Portable EEG devices for point-of-care seizure diagnosis are provided.
domain founded_year HQ Location
Primary antibodies and instruments for immunohistochemistry are manufactured.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Neurovigil

Frequently Asked Questions about Neurovigil

When was Neurovigil founded?

Neurovigil was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Where is Neurovigil located?

Neurovigil is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

Is Neurovigil a funded company?

Neurovigil is a funded company, having raised a total of $250K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on May 30, 2008.

What does Neurovigil do?

NeuroVigil is a neuroscience company focused on the analysis of brain signal or EEG data, which is used in numerous medical applications but is not automated. Its patent-pending and proprietary technology provides automated, and accurate reading and interpretation of EEG data, which is a window to the functioning of the brain. The technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which may lead in the future to neural signatures, or correlates of important disease states, that will be useful in early detection and diagnosis of important medical conditions. NeuroVigil is the winner of the fourth annual DFJ Venture Challenge, a business plan competition sponsored by Draper Fisher Jurvetson (DFJ), DFJ Frontier, and Zone Ventures, that awards 250,000 in seed funding to the winner.

Who are the top competitors of Neurovigil?

Neurovigil's top competitors include Ceribell, Biocare Medical and INBRAIN Neuroelectronics.

What products or services does Neurovigil offer?

Neurovigil offers iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS).

Who are Neurovigil's investors?

Neurovigil has 3 investors. Key investors include DFJ, Zone Ventures, and Draper Frontier.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available